Source: Brownfield AG News

VLS: Verdesian Life Sciences announces new investor

Verdesian Life Sciences is a leader in developing patented biological, nutritional, fertilizer enhancers, seed treatment and inoculant technologies for high-value specialty crops, row crops, and turf and ornamental markets. Recently the company announced an investment from AEA Investors. President and CEO Kenny Avery sat down with Brownfield to talk about the business, the vision for the future, and the role Verdesian plays in improving farmers profitability. AUDIO: Kenny Avery, president and CEO, Verdesian Life Sciences ...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Kenneth Avery's photo - CEO of VLS

CEO

Kenneth Avery

CEO Approval Rating

89/100

Read more